Ann: Acting CEO Outlines Immediate Plans for Novogen, page-48

First 48 Last

Share
Profile

Follow
onesurfed

2,073 Posts.

443

30/07/15

13:20

Post #: 15721053
Share

Originally posted by Pbnewby ↑

Moosey they didn't have the cash to do everything - hats off to GK for raising the funds he did in the last CR - it has set the company up for the lead 3 drugs - Cantrixil, Anisina & Trilexium covering them for the next 2-3 years depending on how hard they push and resources devoted.

As to the Jacob's Hope or non-oncology side as the picture becomes clearer on the effectiveness of the 3 main candidates (for oncology), so the realisation of the non-oncology potential will also grow as the science becomes clearer & clearer.

I think Ross spelt out the challenge when he said:

"Notwithstanding, it is clear that we cannot realistically undertake and fully resource all our research and development programs in parallel all the way through to market approval and launch. These are new ground-breaking and first in class technologies and it is critical that we understand which indications, stage of disease and combinations with other oncology agents will deliver the best outcome for patients and value for shareholders."

Imagine the pressure from parents of young children who have contributed money to programs like Kids for cancer as they watch young go down - I'd be pulling Gunnings door down demanding to know why the delays..

To many programs going in to many directions and not enough funds and everyone wanting things straight away - must have been a hell of a time for GK to try and manage all that and may well have given him the drive to succeed on that last CR.

This is a case of "too much of a good thing". -OS

Expand

Last edited by onesurfed: 30/07/15

NRT Price at posting: 20.0¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

What's causing the cost-of-living crisis, and how to navigate it

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon